Pfizer Ltd. (PFIZER) 52 Week Low Streak: Second Straight Session Sets Fresh One-Year Low
- September 10, 2026
- Posted by: Harsh Piplani
- Category: News
Pfizer Ltd. has now set a fresh 52-week low for its second straight session, with the streak down 10.2% cumulatively from the first break in the sequence. The latest trough is Rs 4,118.05, while the stock last traded at Rs 4,125.6. The supplied data confirms the repeated-low pattern, but it does not establish a company-specific cause for the continued decline.
Compared with the previous close of Rs 4,171.35, the share opened at Rs 4,171.55, touched an intraday high of Rs 4,195.15 and slipped to a day low that also became the fresh 52-week low. Turnover stood at Rs 0.16 crore and market capitalisation at Rs 19,733.06 crore. For a reader, a second straight one-year low is more meaningful than a single-day breakdown because it shows the weakness has persisted across sessions, not just one trading day.
Pfizer Ltd. 52 Week Low Streak: Consecutive Low Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 4,125.6 |
| Previous Close | Rs 4,171.35 |
| Today's Move | Rs -45.75 (-1.1%) |
| Open | Rs 4,171.55 |
| High | Rs 4,195.15 |
| Low | Rs 4,118.05 |
| Turnover | Rs 0.16 crore |
| Market Capitalisation | Rs 19,733.06 crore |
Pfizer Ltd. (PFIZER) traded at Rs 4,125.6 versus the previous close of Rs 4,171.35, a fall of 1.1%. The stock opened at Rs 4,171.55, reached a high of Rs 4,195.15, touched a low of Rs 4,118.05.
Pfizer Ltd. Share Price Today shows a softer close than the previous session, with the stock ending at Rs 4,125.6 against the previous close of Rs 4,171.35. That is a decline of Rs 45.75, or 1.1%, and it kept Pfizer Ltd. Share Price Today near the lower end of the day’s range. The stock opened at Rs 4,171.55, briefly moved up to Rs 4,195.15 and then slid to Rs 4,118.05, which matched the fresh 52-week low for the session.
The close sat only marginally above the day’s low, which underlines how the stock finished the session. Turnover was Rs 0.16 crore and market capitalisation was Rs 19,733.06 crore. In a 52 week low stocks screen, the key point is not only the day’s percentage change but the fact that the low itself was reset again. That makes this Pfizer Ltd. share price update different from a normal intraday decline and more relevant for tracking the stock’s 52 Week Low Streak.
What the Repeated 52-Week Lows Show
Pfizer Ltd. 52 Week Low Streak now reflects two consecutive sessions of new one-year lows, which is the central pattern investors should focus on. The cumulative move across the streak is down 10.2%, and the current low sits at Rs 4,118.05. That repeated-low pattern matters because it captures how the stock has behaved over multiple sessions, rather than isolating one day’s fall. This is the core difference between a one-off 52-week low and a broader Pfizer Ltd. Consecutive 52 Week Low setup.
The data also lets readers compare the latest trough with the prior 52-week low from the first day of the streak, even though the earlier low figure itself is not supplied here. What is clear is that the stock has kept moving to a lower one-year floor on each session of the streak. The supplied information confirms the price pattern, but it does not confirm whether the move is being driven by a specific company event, sector-wide sentiment or any other single trigger.
For investors following Pfizer Ltd. New One Year Low headlines, the main takeaway is that the stock has not just touched a yearly low once; it has repeated that pattern. That is why back to back 52 week lows are watched closely in stock market research, especially when the decline is measured over more than one session.
Pfizer Ltd. (PFIZER) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 19,733.06 crore |
| P/E Ratio | 25.96x |
| P/B Ratio | 4.33x |
| ROE | 17.16% |
| ROCE | 23.39% |
| EPS | Rs 160.7 |
| Book Value Per Share | Rs 963.41 |
| Dividend Yield | 1.8% |
Pfizer Ltd. (PFIZER) fundamental metrics show P/E 25.96x, P/B 4.33x, ROE 17.16%, ROCE 23.39%. These figures provide context only and are not a buy or sell signal.
Pfizer Ltd. has a market capitalisation of Rs 19733.06 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 25.96x, P/B at 4.33x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 17.16% and ROCE of 23.39%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 160.7, book value per share of Rs 963.41, dividend yield of 1.8%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.91x, median ROE of 11.82%, median ROCE of 13.71%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 25.96x |
| Benchmark Median P/E | 32.91x |
| Benchmark Average P/E | 49.23x |
| Benchmark P/E Range | 3.4x to 706.55x |
| Company P/B Ratio | 4.33x |
| Benchmark Median P/B | 2.99x |
| Company ROE | 17.16% |
| Benchmark Median ROE | 11.82% |
| Company ROCE | 23.39% |
| Benchmark Median ROCE | 13.71% |
| Company Market Capitalisation | Rs 19,733.06 crore |
| Benchmark Median Market Cap | Rs 729.92 crore |
Pfizer Ltd. (PFIZER) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Pfizer Ltd. (PFIZER) has a P/E ratio of 25.96x, which is below the benchmark median of 32.91x, a difference of -21.12%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Pfizer Ltd. (PFIZER) has a ROE of 17.16%, which is above the benchmark median of 11.82%, a difference of +45.18%. Pfizer Ltd. (PFIZER) has a ROCE of 23.39%, which is above the benchmark median of 13.71%, a difference of +70.61%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Shilpa Medicare Ltd. | SHILPAMED | 18,764.12 | 63.25 | 7 | 9.82 | 11.43 |
| Caplin Point Laboratories Ltd. | CAPLIPOINT | 21,096.67 | 31.15 | 5.64 | 20.79 | 24.97 |
| Eris Lifesciences Ltd. | ERIS | 18,363.67 | 28.74 | 4.59 | 19.23 | 14.47 |
| Granules India Ltd. | GRANULES | 22,208.8 | 33.04 | 4.47 | 14.13 | 15.74 |
| Suven Pharmaceuticals Ltd. | COHANCE | 17,272.36 | 159.55 | 4.4 | 4.02 | 6.12 |
Pfizer Ltd. (PFIZER) has a P/E ratio of 25.96x compared with the displayed peer median of 33.04x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 17.16% compares with a peer median of 14.13% across the companies shown in the table. ROCE stood at 23.39% versus the displayed peer median of 14.47%, providing a capital-efficiency comparison. Pfizer Ltd. (PFIZER) has a market capitalisation of Rs 19,733.06 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching
- Pfizer Ltd. 52 Week Low Streak has now extended to a second straight session, making the price pattern more important than a one-day fall.
- The cumulative decline across the streak is 10.2%, which gives a clearer read than the latest 1.1% move alone.
- The current low of Rs 4,118.05 keeps Pfizer Ltd. in the “52 Week Low Stocks” bucket and near the centre of stock market screens.
- Fundamental ratios such as ROE and ROCE remain above the sector median, so the weakness is not explained by a simple profitability collapse in the supplied data.
- Investors may keep watching whether Pfizer Ltd. New One Year Low levels continue to reset, or whether the streak pauses in the next session.
About the Company
Pfizer Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector and is listed on the Indian stock market under NSE and BSE tracking frameworks. The company’s current market capitalisation is Rs 19,733.06 crore, placing it among the more valuable names in its peer set supplied here. Its EPS of Rs 160.7 and book value of Rs 963.41 provide a snapshot of earnings and equity backing, while the dividend yield is 1.8%.
Pfizer Ltd. Share Price movement in recent sessions has been defined by the repeated one-year low pattern rather than by a broad base-building move. That is why Pfizer Ltd. Share Price Today is being watched closely in the context of stock news, sector analysis and company news. The available data supports a market update, not a reasoned conclusion on management actions or a specific event driver.
Track Pfizer Ltd. on Univest
Track Pfizer Ltd. 52 Week Low Streak on Univest for updated share price movement, fresh one-year low markers, company news and stock performance context. The stock page can help readers follow the evolving Pfizer Ltd. Share Price Today setup alongside sector and peer comparisons.
Frequently Asked Questions
What does Pfizer Ltd. 52 Week Low Streak mean?
Ans. It means Pfizer Ltd. has set a fresh 52-week low in consecutive sessions. In this case, the stock has done so for a second straight session, which shows the weakness has persisted beyond a single trading day.
How does Pfizer Ltd. compare with peers on valuation?
Ans. Pfizer Ltd. trades at a P/E of 25.96, below the sector median of 32.91, and a P/B of 4.33, slightly above the sector median of 2.99. That places it in a mixed valuation position versus the supplied peer set.
Is Pfizer Ltd. a good stock analysis case for sector comparison?
Ans. Yes, because the company combines a repeated 52-week low pattern with above-median ROE and ROCE in the supplied sector data. That makes it useful for Pfizer Ltd. Stock Analysis and Healthcare sector comparison.
What should investors monitor next in Pfizer Ltd. Share Price Today?
Ans. Investors can monitor whether the stock continues to reset the yearly low, whether the repeated-low pattern stops, and how the market reads the current valuation relative to peers. The next session will be important for the streak narrative.
Track Pfizer Ltd. (PFIZER) Share Price on Univest
Use Pfizer Ltd. (PFIZER) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
